103
Views
6
CrossRef citations to date
0
Altmetric
Patent Evaluation

Pyrazole trk kinase inhibitors for the treatment of cancer

AstraZeneca: WO06087538 and WO06087530

&
Pages 351-356 | Published online: 20 Feb 2007

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Tao Wang, Dingwei Yu & Michelle L Lamb. (2009) Trk kinase inhibitors as new treatments for cancer and pain. Expert Opinion on Therapeutic Patents 19:3, pages 305-319.
Read now

Articles from other publishers (5)

John U. Chukwu, Concepción López, Asensio González, Mercè Font-Bardía, M. Teresa Calvet, Ramon Messeguer & Carme Calvis. (2014) Pd(II) complexes with N-substituted pyrazoles as ligands. The influence of the R group [OMe versus NMe2] of [1-{R–(CH2)2–}-3,5-Ph2–(C3HN2)] on their cytotoxic activity on breast cancer cell lines. Journal of Organometallic Chemistry 766, pages 13-21.
Crossref
Stéphane L. Raeppel, Frédéric Gaudette, Hannah Nguyen, Normand Beaulieu, James Wang, Christiane Maroun, Jeffrey M. Besterman & Arkadii Vaisburg. (2012) Identification of a Novel Series of Potent TrkA Receptor Tyrosine Kinase Inhibitors. International Journal of Medicinal Chemistry 2012, pages 1-6.
Crossref
Sudipta Roy, Sujata Roy & Gordon W. Gribble. 2012. Metalation of Azoles and Related Five-Membered Ring Heterocycles. Metalation of Azoles and Related Five-Membered Ring Heterocycles 155 260 .
Ramsay E. Beveridge, Dilinie Fernando & Brian S. Gerstenberger. (2010) One-pot copper-catalyzed synthesis of N-functionalized pyrazoles from boronic acids. Tetrahedron Letters 51:38, pages 5005-5008.
Crossref
Rabindranath Tripathy, Thelma S. Angeles, Shi X. Yang & John P. Mallamo. (2008) TrkA kinase inhibitors from a library of modified and isosteric Staurosporine aglycone. Bioorganic & Medicinal Chemistry Letters 18:12, pages 3551-3555.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.